Alternatives to HealthSpan Labs

Irish BioTech startup Aerska raises €32 million to enable loved ones to live longer.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Biotechnology company focused on developing therapies to extend human healthspan and reverse aging.

Biotech company focused on developing therapies to extend human healthspan and lifespan.

BioAge Labs is a biotechnology company focused on developing therapies to extend human healthspan and lifespan.

Omega Therapeutics is developing a new class of programmable medicines called Epigenomic Controllers.

Developing novel therapies to reverse aging and extend lifespan.

Leveraging the adaptive immune system to diagnose and treat disease.

Developing epigenetic reprogramming drugs for age restoration.

Biotech company

A global oncology company developing and commercializing innovative cancer treatments.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Mapping cell-cell communication at scale in human tissue.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Developing novel therapeutics for neurodegenerative diseases using advanced biological insights.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

AI-powered platform for personalized cell therapy development and manufacturing.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Advance every cancer decision.

Gene therapy company developing treatments for rare inherited diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Developing novel therapeutics for age-related diseases using senolytic compounds.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Global marketplace connecting researchers with human biospecimens for life science research.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Develops senolytic drugs to clear senescent cells and promote cellular rejuvenation.

Developing transformative fusion immunotherapeutics for autoimmune diseases, cancer, and senescence-associated dysplasia.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

Biotech company focused on designing and developing novel biological solutions.

AI-powered platform for antibody discovery and development to create new medicines.

Biotechnology company

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

Biostax provides a cloud-based platform for life sciences research, enabling data integration and analysis.

SNIPR Biome is a clinical-stage company developing CRISPR-based therapeutics to precisely target and eliminate specific bacteria in the human microbiome.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

AI-powered platform accelerating biological research and drug discovery.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

Valthos is an applied biological intelligence company. We develop and deploy software and AI methods to outsmart biological evolution and ensure that these tools are deployed to safeguard humanity.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

AI-powered epiproteomic analysis platform for mass spectrometry data.

AI-powered biotech platform using protein design to discover novel therapeutic molecules for hard-to-treat targets.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Narya Bio is developing novel therapeutic antibodies for challenging diseases.